BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33934011)

  • 1. Epidemiology of multiple sclerosis in Lebanon: A rising prevalence in the middle east.
    Zeineddine M; Hajje AA; Hussein A; El Ayoubi N; Yamout B
    Mult Scler Relat Disord; 2021 Jul; 52():102963. PubMed ID: 33934011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of hip fractures in Lebanon: a nationwide survey.
    Maalouf G; Bachour F; Hlais S; Maalouf NM; Yazbeck P; Yaghi Y; Yaghi K; El Hage R; Issa M
    Orthop Traumatol Surg Res; 2013 Oct; 99(6):675-80. PubMed ID: 24007698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and sex adjusted prevalence and annual incidence of multiple sclerosis in East-Azerbaijan, Iran.
    Talebi M; Sadigh-Eteghad S; Sahraian MA; Fahidi A
    Mult Scler Relat Disord; 2021 May; 50():102839. PubMed ID: 33592381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of multiple sclerosis in the Scottish Highlands: Prevalence, incidence and time to confirmed diagnosis and treatment initiation.
    Carod-Artal FJ
    Mult Scler Relat Disord; 2021 Jan; 47():102657. PubMed ID: 33302230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system cancers in the Middle East and North Africa (MENA) region: where does Lebanon stand.
    Salhab HA; Khachfe HH; Fares MY; Belkacemi Y; Hosseini H
    Chin Clin Oncol; 2020 Jun; 9(3):36. PubMed ID: 32389002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and incidence of multiple sclerosis in central Poland, 2010-2014.
    Brola W; Sobolewski P; Flaga S; Fudala M; Szczuchniak W; Stoiński J; Rosołowska A; Wójcik J; Kapica-Topczewska K; Ryglewicz D
    BMC Neurol; 2016 Aug; 16(1):134. PubMed ID: 27516084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis in the Levant: a regional consensus statement.
    Yamout B; El-Salem K; Gebeily S; Khoury S; Abu Zeid N; Hamoulila K; Alhalabi MS; Hasan ZN; Al Hamadani H; Hamoodi H; Al Omar A; Dahdaleh M
    Int J Neurosci; 2014 May; 124(5):377-82. PubMed ID: 23927564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
    Costa Arpín E; Naveiro Soneira J; Lema Bouzas M; González Quintela A; Prieto González JM
    Acta Neurol Scand; 2020 Sep; 142(3):267-274. PubMed ID: 32392359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing prevalence and incidence rates of multiple sclerosis in Kuwait.
    Alroughani R; Ahmed SF; Behbahani R; Khan R; Thussu A; Alexander KJ; Ashkanani A; Nagarajan V; Al-Hashel J
    Mult Scler; 2014 Apr; 20(5):543-7. PubMed ID: 24025709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database.
    Mackenzie IS; Morant SV; Bloomfield GA; MacDonald TM; O'Riordan J
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):76-84. PubMed ID: 24052635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervix Uteri Cancer in Lebanon: Incidence, Temporal Trends, and Comparison to Countries From Different Regions in the World.
    Lakkis NA; Osman MH; Abdallah RM
    Cancer Control; 2022; 29():10732748211068634. PubMed ID: 35012377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological Study of Lung Cancer Incidence in Lebanon.
    Salhab HA; Fares MY; Khachfe HH; Khachfe HM
    Medicina (Kaunas); 2019 May; 55(6):. PubMed ID: 31141934
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of multiple sclerosis in France in 2021: Data from the French health insurance database.
    Pierret C; Mainguy M; Leray E
    Rev Neurol (Paris); 2024 May; 180(5):429-437. PubMed ID: 38423846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Epidemiology among Lebanese Women: An 11-Year Analysis.
    Fares MY; Salhab HA; Khachfe HH; Khachfe HM
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31405167
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence and prevalence of multiple sclerosis in persian gulf area: A systematic review and meta-analysis.
    Etemadifar M; Nikanpour Y; Neshatfar A; Mansourian M; Fitzgerald S
    Mult Scler Relat Disord; 2020 May; 40():101959. PubMed ID: 31991397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
    Grytten N; Aarseth JH; Lunde HM; Myhr KM
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):100-5. PubMed ID: 25714916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSN MS guidelines for the management of multiple sclerosis.
    Shatila AR; Koussa S; Jabbour R; Mourad A; Aouad A; Sabbagh G; Kallab K; Hilal R; Khalifeh R; Gebeily S; Tourbah A;
    Rev Neurol (Paris); 2013 Dec; 169(12):950-5. PubMed ID: 23434141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence and increasing incidence of multiple sclerosis in the Norwegian county of Buskerud.
    Simonsen CS; Edland A; Berg-Hansen P; Celius EG
    Acta Neurol Scand; 2017 Apr; 135(4):412-418. PubMed ID: 27241360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.
    Sarmadi M; Saravani H; Azizi O; Najafi F; Hadei M; Momeni J; Bazrafshan E
    Neurol Sci; 2022 Jan; 43(1):583-591. PubMed ID: 33939041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland.
    Gray OM; McDonnell GV; Hawkins SA
    Mult Scler; 2008 Aug; 14(7):880-6. PubMed ID: 18573832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.